Merging clinical research and standard healthcare – Nordic Precision Cancer Medicine Symposium 2025

The implementation of PCM in standard healthcare is progressing but several hurdles remain.Key challenges include unequal access to advanced diagnostics, uncertainties regarding the real-world effectiveness of targeted treatments, and issues related to reimbursement and co-payment for patients.In addition, there is a need for enhanced education and training for healthcare providers to effectively interpret genomic data and integrate it into clinical practice.Overcoming these barriers requires coordinated efforts among healthcare providers, policymakers, and stakeholders to ensure that PCM can be effectively incorporated into routine clinical practice, ultimately enhancing patient outcomes and equity in cancer care.The second Nordic Precision Cancer Medicine Symposium brought together experts from different areas important for PCM implementation into standard healthcare, and topics addressed during the conference included precision diagnostics, functional precision oncology, precision immune-oncology, clinical trials as well as PCM implementation.In addition, current Nordic cancer strategies and PCM was discussed.This special edition focusing on PCM, includes publications from altogether 13 speakers and poster presenters from the NPCM2025 conference.